Logo Goletty

Traditional Antidotes Kallunk Oxide in the Treatment of HIV/AIDS
Journal Title Indian Journal of Science and Technology
Journal Abbreviation indjst
Publisher Group Informatics (India) Limited (gjeis)
Website http://gjeis.org/index.php/indjst
PDF (187 kb)
   
Title Traditional Antidotes Kallunk Oxide in the Treatment of HIV/AIDS
Authors Madhusoodanan, Ramakrishnan
Abstract Immune deficiency is an important problem on HIV/AIDS patients. Traditional antidotes "Kallunk oxide", a Complementary and Alternative Medicine (CAM), could be better restored the immunity in initial stage of HIV type-1 patients. The performed modest phase-1 study was observational, prospective and designs as open label, case- only, randomized, treatment, and efficacy research enrolled with CD3+ and CD4+ T cell counts >450, >250 and 3 of 20 HIV/AIDS patients between the ages 8 and 55 years from both genders at the Project Site Office, HIRS, Palakkad- Dt, Kerala, India. The participants were received traditional antidotes "Kallunk oxide" treatment and the study includes Lymphocyte cell counts as assessed by Flow fluorescence cytometry analysis. The absolute CD3+ and CD4+ T cell numbers increased in four (4) HIV type-1 patients, as confirmed by the baseline CD4+ T cell counts above 450 cu/mm3, showing above 50% increase after the CAM therapy. This traditional antidotes "Kallunk oxide" treatment boosts initial stage of HIV type-1 patients´ immunity.
Publisher Indian Society for Education and Environment (ISEE)
Date 2011-12-01
Source Indian Journal of Science and Technology Volume 4, Issue 12, December 2011

 

See other article in the same Issue


Goletty © 2024